Global Recombinant Human Growth Hormone Market Research Report 2025

Industry: Pharma & Healthcare

Published: 2025-01-01

Pages: 96 Pages

Report ld: 3446169

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Recombinant Human Growth Hormone was valued at US$ 4617 million in the year 2024 and is projected to reach a revised size of US$ 7945 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Recombinant human growth hormone is produced by gene recombinant Escherichia coli secretory expression technology, and it is completely consistent with human pituitary growth hormone in amino acid content, sequence and protein structure. In the field of pediatrics, replacement therapy with recombinant human growth hormone can significantly promote children"s height growth and improve the growth and development of various organs and tissues throughout the body. At the same time, recombinant human growth hormone also plays an important role in the fields of reproduction, burns and anti-aging.

North American market for Recombinant Human Growth Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Human Growth Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Recombinant Human Growth Hormone include Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck Serono, F.Hoffmann-La Roche, Ispen, Sandoz International, Changchun High-Tech Industries, Shenzhen Kexing Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Growth Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Growth Hormone.

The Recombinant Human Growth Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Growth Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Growth Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Report Metric
Details
Report Title
Global Recombinant Human Growth Hormone Market Research Report 2025
CAGR(2025-2031)
8.2%
Market Size Available for Years
2025-2031
Global Recombinant Human Growth Hormone Companies Covered
Novo Nordisk
LG Chem
Pfizer
Eli lilly
Merck Serono
F.Hoffmann-La Roche
Ispen
Sandoz International
Changchun High-Tech Industries
Shenzhen Kexing Pharmaceutical
Changchun GeneScience Pharmaceutical
Anhui Anke Biotechnology
Global Recombinant Human Growth Hormone Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Human Growth Hormone Market, Segment by Type
Powder Injection
Water Injection
Global Recombinant Human Growth Hormone Market, Segment by Application
Childhood Growth Hormone Deficiency
Chronic Renal Insufficiency
HIV Infection-Associated Wasting Syndrome
Adult GHD Replacement Therapy
Small For Gestational Age (SGA)
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Growth Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Recombinant Human Growth Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Recombinant Human Growth Hormone Market Overview
    1.1 Product Definition
    1.2 Recombinant Human Growth Hormone by Type
        1.2.1 Global Recombinant Human Growth Hormone Market Value Comparison by Type (2024 VS 2031)
        1.2.2 Powder Injection
        1.2.3 Water Injection
    1.3 Recombinant Human Growth Hormone by Application
        1.3.1 Global Recombinant Human Growth Hormone Market Value by Application (2024 VS 2031)
        1.3.2 Childhood Growth Hormone Deficiency
        1.3.3 Chronic Renal Insufficiency
        1.3.4 HIV Infection-Associated Wasting Syndrome
        1.3.5 Adult GHD Replacement Therapy
        1.3.6 Small For Gestational Age (SGA)
        1.3.7 Others
    1.4 Global Recombinant Human Growth Hormone Market Size Estimates and Forecasts
        1.4.1 Global Recombinant Human Growth Hormone Revenue 2020-2031
        1.4.2 Global Recombinant Human Growth Hormone Sales 2020-2031
        1.4.3 Global Recombinant Human Growth Hormone Market Average Price (2020-2031)
    1.5 Assumptions and Limitations

2 Recombinant Human Growth Hormone Market Competition by Manufacturers
    2.1 Global Recombinant Human Growth Hormone Sales Market Share by Manufacturers (2020-2025)
    2.2 Global Recombinant Human Growth Hormone Revenue Market Share by Manufacturers (2020-2025)
    2.3 Global Recombinant Human Growth Hormone Average Price by Manufacturers (2020-2025)
    2.4 Global Key Players of Recombinant Human Growth Hormone, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Recombinant Human Growth Hormone, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Recombinant Human Growth Hormone, Product Type & Application
    2.7 Global Key Manufacturers of Recombinant Human Growth Hormone, Date of Enter into This Industry
    2.8 Global Recombinant Human Growth Hormone Market Competitive Situation and Trends
        2.8.1 Global Recombinant Human Growth Hormone Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Recombinant Human Growth Hormone Players Market Share by Revenue
        2.8.3 Global Recombinant Human Growth Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Recombinant Human Growth Hormone Market Scenario by Region
    3.1 Global Recombinant Human Growth Hormone Market Size by Region: 2020 Versus 2024 Versus 2031
    3.2 Global Recombinant Human Growth Hormone Sales by Region: 2020-2031
        3.2.1 Global Recombinant Human Growth Hormone Sales by Region: 2020-2025
        3.2.2 Global Recombinant Human Growth Hormone Sales by Region: 2026-2031
    3.3 Global Recombinant Human Growth Hormone Revenue by Region: 2020-2031
        3.3.1 Global Recombinant Human Growth Hormone Revenue by Region: 2020-2025
        3.3.2 Global Recombinant Human Growth Hormone Revenue by Region: 2026-2031
    3.4 North America Recombinant Human Growth Hormone Market Facts & Figures by Country
        3.4.1 North America Recombinant Human Growth Hormone Market Size by Country: 2020 VS 2024 VS 2031
        3.4.2 North America Recombinant Human Growth Hormone Sales by Country (2020-2031)
        3.4.3 North America Recombinant Human Growth Hormone Revenue by Country (2020-2031)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Recombinant Human Growth Hormone Market Facts & Figures by Country
        3.5.1 Europe Recombinant Human Growth Hormone Market Size by Country: 2020 VS 2024 VS 2031
        3.5.2 Europe Recombinant Human Growth Hormone Sales by Country (2020-2031)
        3.5.3 Europe Recombinant Human Growth Hormone Revenue by Country (2020-2031)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Recombinant Human Growth Hormone Market Facts & Figures by Region
        3.6.1 Asia Pacific Recombinant Human Growth Hormone Market Size by Region: 2020 VS 2024 VS 2031
        3.6.2 Asia Pacific Recombinant Human Growth Hormone Sales by Region (2020-2031)
        3.6.3 Asia Pacific Recombinant Human Growth Hormone Revenue by Region (2020-2031)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Recombinant Human Growth Hormone Market Facts & Figures by Country
        3.7.1 Latin America Recombinant Human Growth Hormone Market Size by Country: 2020 VS 2024 VS 2031
        3.7.2 Latin America Recombinant Human Growth Hormone Sales by Country (2020-2031)
        3.7.3 Latin America Recombinant Human Growth Hormone Revenue by Country (2020-2031)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Recombinant Human Growth Hormone Market Facts & Figures by Country
        3.8.1 Middle East and Africa Recombinant Human Growth Hormone Market Size by Country: 2020 VS 2024 VS 2031
        3.8.2 Middle East and Africa Recombinant Human Growth Hormone Sales by Country (2020-2031)
        3.8.3 Middle East and Africa Recombinant Human Growth Hormone Revenue by Country (2020-2031)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

4 Segment by Type
    4.1 Global Recombinant Human Growth Hormone Sales by Type (2020-2031)
        4.1.1 Global Recombinant Human Growth Hormone Sales by Type (2020-2025)
        4.1.2 Global Recombinant Human Growth Hormone Sales by Type (2026-2031)
        4.1.3 Global Recombinant Human Growth Hormone Sales Market Share by Type (2020-2031)
    4.2 Global Recombinant Human Growth Hormone Revenue by Type (2020-2031)
        4.2.1 Global Recombinant Human Growth Hormone Revenue by Type (2020-2025)
        4.2.2 Global Recombinant Human Growth Hormone Revenue by Type (2026-2031)
        4.2.3 Global Recombinant Human Growth Hormone Revenue Market Share by Type (2020-2031)
    4.3 Global Recombinant Human Growth Hormone Price by Type (2020-2031)

5 Segment by Application
    5.1 Global Recombinant Human Growth Hormone Sales by Application (2020-2031)
        5.1.1 Global Recombinant Human Growth Hormone Sales by Application (2020-2025)
        5.1.2 Global Recombinant Human Growth Hormone Sales by Application (2026-2031)
        5.1.3 Global Recombinant Human Growth Hormone Sales Market Share by Application (2020-2031)
    5.2 Global Recombinant Human Growth Hormone Revenue by Application (2020-2031)
        5.2.1 Global Recombinant Human Growth Hormone Revenue by Application (2020-2025)
        5.2.2 Global Recombinant Human Growth Hormone Revenue by Application (2026-2031)
        5.2.3 Global Recombinant Human Growth Hormone Revenue Market Share by Application (2020-2031)
    5.3 Global Recombinant Human Growth Hormone Price by Application (2020-2031)

6 Key Companies Profiled
    6.1 Novo Nordisk
        6.1.1 Novo Nordisk Company Information
        6.1.2 Novo Nordisk Description and Business Overview
        6.1.3 Novo Nordisk Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.1.4 Novo Nordisk Recombinant Human Growth Hormone Product Portfolio
        6.1.5 Novo Nordisk Recent Developments/Updates
    6.2 LG Chem
        6.2.1 LG Chem Company Information
        6.2.2 LG Chem Description and Business Overview
        6.2.3 LG Chem Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.2.4 LG Chem Recombinant Human Growth Hormone Product Portfolio
        6.2.5 LG Chem Recent Developments/Updates
    6.3 Pfizer
        6.3.1 Pfizer Company Information
        6.3.2 Pfizer Description and Business Overview
        6.3.3 Pfizer Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.3.4 Pfizer Recombinant Human Growth Hormone Product Portfolio
        6.3.5 Pfizer Recent Developments/Updates
    6.4 Eli lilly
        6.4.1 Eli lilly Company Information
        6.4.2 Eli lilly Description and Business Overview
        6.4.3 Eli lilly Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.4.4 Eli lilly Recombinant Human Growth Hormone Product Portfolio
        6.4.5 Eli lilly Recent Developments/Updates
    6.5 Merck Serono
        6.5.1 Merck Serono Company Information
        6.5.2 Merck Serono Description and Business Overview
        6.5.3 Merck Serono Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.5.4 Merck Serono Recombinant Human Growth Hormone Product Portfolio
        6.5.5 Merck Serono Recent Developments/Updates
    6.6 F.Hoffmann-La Roche
        6.6.1 F.Hoffmann-La Roche Company Information
        6.6.2 F.Hoffmann-La Roche Description and Business Overview
        6.6.3 F.Hoffmann-La Roche Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.6.4 F.Hoffmann-La Roche Recombinant Human Growth Hormone Product Portfolio
        6.6.5 F.Hoffmann-La Roche Recent Developments/Updates
    6.7 Ispen
        6.7.1 Ispen Company Information
        6.7.2 Ispen Description and Business Overview
        6.7.3 Ispen Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.7.4 Ispen Recombinant Human Growth Hormone Product Portfolio
        6.7.5 Ispen Recent Developments/Updates
    6.8 Sandoz International
        6.8.1 Sandoz International Company Information
        6.8.2 Sandoz International Description and Business Overview
        6.8.3 Sandoz International Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.8.4 Sandoz International Recombinant Human Growth Hormone Product Portfolio
        6.8.5 Sandoz International Recent Developments/Updates
    6.9 Changchun High-Tech Industries
        6.9.1 Changchun High-Tech Industries Company Information
        6.9.2 Changchun High-Tech Industries Description and Business Overview
        6.9.3 Changchun High-Tech Industries Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.9.4 Changchun High-Tech Industries Recombinant Human Growth Hormone Product Portfolio
        6.9.5 Changchun High-Tech Industries Recent Developments/Updates
    6.10 Shenzhen Kexing Pharmaceutical
        6.10.1 Shenzhen Kexing Pharmaceutical Company Information
        6.10.2 Shenzhen Kexing Pharmaceutical Description and Business Overview
        6.10.3 Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.10.4 Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Product Portfolio
        6.10.5 Shenzhen Kexing Pharmaceutical Recent Developments/Updates
    6.11 	Changchun GeneScience Pharmaceutical
        6.11.1 	Changchun GeneScience Pharmaceutical Company Information
        6.11.2 	Changchun GeneScience Pharmaceutical Description and Business Overview
        6.11.3 	Changchun GeneScience Pharmaceutical Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.11.4 	Changchun GeneScience Pharmaceutical Recombinant Human Growth Hormone Product Portfolio
        6.11.5 	Changchun GeneScience Pharmaceutical Recent Developments/Updates
    6.12 Anhui Anke Biotechnology
        6.12.1 Anhui Anke Biotechnology Company Information
        6.12.2 Anhui Anke Biotechnology Description and Business Overview
        6.12.3 Anhui Anke Biotechnology Recombinant Human Growth Hormone Sales, Revenue and Gross Margin (2020-2025)
        6.12.4 Anhui Anke Biotechnology Recombinant Human Growth Hormone Product Portfolio
        6.12.5 Anhui Anke Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
    7.1 Recombinant Human Growth Hormone Industry Chain Analysis
    7.2 Recombinant Human Growth Hormone Raw Material Supply Analysis
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Recombinant Human Growth Hormone Production Mode & Process Analysis
    7.4 Recombinant Human Growth Hormone Sales and Marketing
        7.4.1 Recombinant Human Growth Hormone Sales Channels
        7.4.2 Recombinant Human Growth Hormone Distributors
    7.5 Recombinant Human Growth Hormone Customer Analysis

8 Recombinant Human Growth Hormone Market Dynamics
    8.1 Recombinant Human Growth Hormone Industry Trends
    8.2 Recombinant Human Growth Hormone Market Drivers
    8.3 Recombinant Human Growth Hormone Market Challenges
    8.4 Recombinant Human Growth Hormone Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Recombinant Human Growth Hormone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Human Growth Hormone Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Human Growth Hormone Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Human Growth Hormone Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Human Growth Hormone Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Human Growth Hormone Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Human Growth Hormone Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Human Growth Hormone, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Human Growth Hormone, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Human Growth Hormone, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Human Growth Hormone, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Human Growth Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Growth Hormone as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Human Growth Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Human Growth Hormone Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Human Growth Hormone Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Human Growth Hormone Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Human Growth Hormone Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Human Growth Hormone Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Human Growth Hormone Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Human Growth Hormone Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Human Growth Hormone Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Human Growth Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Human Growth Hormone Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Human Growth Hormone Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Human Growth Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Human Growth Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Human Growth Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Human Growth Hormone Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Human Growth Hormone Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Human Growth Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Human Growth Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Human Growth Hormone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Human Growth Hormone Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Human Growth Hormone Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Human Growth Hormone Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Human Growth Hormone Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Human Growth Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Human Growth Hormone Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Human Growth Hormone Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Human Growth Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Human Growth Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Human Growth Hormone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Human Growth Hormone Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Human Growth Hormone Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Human Growth Hormone Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Human Growth Hormone Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Human Growth Hormone Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Human Growth Hormone Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Human Growth Hormone Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Human Growth Hormone Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Human Growth Hormone Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Human Growth Hormone Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Human Growth Hormone Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Human Growth Hormone Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Human Growth Hormone Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Human Growth Hormone Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Human Growth Hormone Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Human Growth Hormone Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Human Growth Hormone Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Human Growth Hormone Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Human Growth Hormone Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Human Growth Hormone Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Human Growth Hormone Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Recombinant Human Growth Hormone Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. LG Chem Company Information
 Table 76. LG Chem Description and Business Overview
 Table 77. LG Chem Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. LG Chem Recombinant Human Growth Hormone Product
 Table 79. LG Chem Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Recombinant Human Growth Hormone Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Eli lilly Company Information
 Table 86. Eli lilly Description and Business Overview
 Table 87. Eli lilly Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Eli lilly Recombinant Human Growth Hormone Product
 Table 89. Eli lilly Recent Developments/Updates
 Table 90. Merck Serono Company Information
 Table 91. Merck Serono Description and Business Overview
 Table 92. Merck Serono Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Merck Serono Recombinant Human Growth Hormone Product
 Table 94. Merck Serono Recent Developments/Updates
 Table 95. F.Hoffmann-La Roche Company Information
 Table 96. F.Hoffmann-La Roche Description and Business Overview
 Table 97. F.Hoffmann-La Roche Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. F.Hoffmann-La Roche Recombinant Human Growth Hormone Product
 Table 99. F.Hoffmann-La Roche Recent Developments/Updates
 Table 100. Ispen Company Information
 Table 101. Ispen Description and Business Overview
 Table 102. Ispen Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ispen Recombinant Human Growth Hormone Product
 Table 104. Ispen Recent Developments/Updates
 Table 105. Sandoz International Company Information
 Table 106. Sandoz International Description and Business Overview
 Table 107. Sandoz International Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Sandoz International Recombinant Human Growth Hormone Product
 Table 109. Sandoz International Recent Developments/Updates
 Table 110. Changchun High-Tech Industries Company Information
 Table 111. Changchun High-Tech Industries Description and Business Overview
 Table 112. Changchun High-Tech Industries Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Changchun High-Tech Industries Recombinant Human Growth Hormone Product
 Table 114. Changchun High-Tech Industries Recent Developments/Updates
 Table 115. Shenzhen Kexing Pharmaceutical Company Information
 Table 116. Shenzhen Kexing Pharmaceutical Description and Business Overview
 Table 117. Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shenzhen Kexing Pharmaceutical Recombinant Human Growth Hormone Product
 Table 119. Shenzhen Kexing Pharmaceutical Recent Developments/Updates
 Table 120. 
 Table 121. 
 Table 122. 
 Table 123. 
 Table 124. 
 Table 125. Anhui Anke Biotechnology Company Information
 Table 126. Anhui Anke Biotechnology Description and Business Overview
 Table 127. Anhui Anke Biotechnology Recombinant Human Growth Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Anhui Anke Biotechnology Recombinant Human Growth Hormone Product
 Table 129. Anhui Anke Biotechnology Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Recombinant Human Growth Hormone Distributors List
 Table 133. Recombinant Human Growth Hormone Customers List
 Table 134. Recombinant Human Growth Hormone Market Trends
 Table 135. Recombinant Human Growth Hormone Market Drivers
 Table 136. Recombinant Human Growth Hormone Market Challenges
 Table 137. Recombinant Human Growth Hormone Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Human Growth Hormone
 Figure 2. Global Recombinant Human Growth Hormone Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Human Growth Hormone Market Share by Type: 2024 & 2031
 Figure 4. Powder Injection Product Picture
 Figure 5. Water Injection Product Picture
 Figure 6. Global Recombinant Human Growth Hormone Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Human Growth Hormone Market Share by Application: 2024 & 2031
 Figure 8. Childhood Growth Hormone Deficiency
 Figure 9. Chronic Renal Insufficiency
 Figure 10. HIV Infection-Associated Wasting Syndrome
 Figure 11. Adult GHD Replacement Therapy
 Figure 12. Small For Gestational Age (SGA)
 Figure 13. Others
 Figure 14. Global Recombinant Human Growth Hormone Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Recombinant Human Growth Hormone Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Recombinant Human Growth Hormone Sales (2020-2031) & (K Units)
 Figure 17. Global Recombinant Human Growth Hormone Average Price (US$/Unit) & (2020-2031)
 Figure 18. Recombinant Human Growth Hormone Report Years Considered
 Figure 19. Recombinant Human Growth Hormone Sales Share by Manufacturers in 2024
 Figure 20. Global Recombinant Human Growth Hormone Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Recombinant Human Growth Hormone Players: Market Share by Revenue in Recombinant Human Growth Hormone in 2024
 Figure 22. Recombinant Human Growth Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Recombinant Human Growth Hormone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Recombinant Human Growth Hormone Sales Market Share by Country (2020-2031)
 Figure 25. North America Recombinant Human Growth Hormone Revenue Market Share by Country (2020-2031)
 Figure 26. United States Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Recombinant Human Growth Hormone Sales Market Share by Country (2020-2031)
 Figure 29. Europe Recombinant Human Growth Hormone Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Recombinant Human Growth Hormone Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Recombinant Human Growth Hormone Revenue Market Share by Region (2020-2031)
 Figure 37. China Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Recombinant Human Growth Hormone Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Recombinant Human Growth Hormone Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Recombinant Human Growth Hormone Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Recombinant Human Growth Hormone Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Recombinant Human Growth Hormone Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Recombinant Human Growth Hormone by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Human Growth Hormone by Type (2020-2031)
 Figure 56. Global Recombinant Human Growth Hormone Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Recombinant Human Growth Hormone by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Recombinant Human Growth Hormone by Application (2020-2031)
 Figure 59. Global Recombinant Human Growth Hormone Price (US$/Unit) by Application (2020-2031)
 Figure 60. Recombinant Human Growth Hormone Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed

Description

The global market for Recombinant Human Growth Hormone was valued at US$ 4617 million in the year 2024 and is projected to reach a revised size of US$ 7945 million by 2031, growing at a CAGR of 8.2% during the forecast period.

Recombinant human growth hormone is produced by gene recombinant Escherichia coli secretory expression technology, and it is completely consistent with human pituitary growth hormone in amino acid content, sequence and protein structure. In the field of pediatrics, replacement therapy with recombinant human growth hormone can significantly promote children"s height growth and improve the growth and development of various organs and tissues throughout the body. At the same time, recombinant human growth hormone also plays an important role in the fields of reproduction, burns and anti-aging.

North American market for Recombinant Human Growth Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Recombinant Human Growth Hormone is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Recombinant Human Growth Hormone include Novo Nordisk, LG Chem, Pfizer, Eli lilly, Merck Serono, F.Hoffmann-La Roche, Ispen, Sandoz International, Changchun High-Tech Industries, Shenzhen Kexing Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Growth Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Growth Hormone.

The Recombinant Human Growth Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Growth Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Recombinant Human Growth Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Growth Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3:  Sales, revenue of Recombinant Human Growth Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Related Reports

Global Recombinant Human Growth Hormone Market Research Report 2024
Recombinant human growth hormone is produced by gene recombinant Escherichia coli secretory expression technology, and it is completely consistent with human pituitary growth hormone in amino acid content, sequence and protein structure. In the field of pediatrics, replacement therapy with recombinant human growth hormone can significantly promote children's height growth and improve the growth and development of various organs and tissues throughout the body. At the same time, recombinant human growth hormone also plays an important role in the fields of reproduction, burns and anti-aging.
Published: 2024-02-07
Pages: 88
USD 2900.00
(Single User License)
Global Recombinant Human Growth Hormone Market Insights, Forecast to 2030
Recombinant human growth hormone is produced by gene recombinant Escherichia coli secretory expression technology, and it is completely consistent with human pituitary growth hormone in amino acid content, sequence and protein structure. In the field of pediatrics, replacement therapy with recombinant human growth hormone can significantly promote children's height growth and improve the growth and development of various organs and tissues throughout the body. At the same time, recombinant human growth hormone also plays an important role in the fields of reproduction, burns and anti-aging.
Published: 2024-04-09
Pages: 106
USD 4900.00
(Single User License)